Sanofi
Cabazitaxel in mCRPC Patients Previously Treated with Docetaxel and Who Failed a Prior androgen signaling targeted inhibitor Agent
Last updated:
Abstract:
Provided herein are methods of using cabazitaxel in mCRPC patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent.
Status:
Application
Type:
Utility
Filling date:
24 Sep 2020
Issue date:
12 Aug 2021